Hospital Nossa Senhora da Conceicao

Porto Alegre 91350-280

0 studies enrolling now · 7 studies all time

What they study most

Asthma, Carcinoma, Squamous Cell, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Lung Cancer, Mantle Cell Lymphoma, Metastatic Breast Cancer, Non-small Cell Lung Cancer, Pancreatic Cancer, Select Advanced Solid Tumors

Studies at this site

• JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC — Recruiting now
• A Study of Valemetostat Tosylate Plus Pembrolizumab Versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic Alterations — Running, not enrolling
• Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors — Running, not enrolling
• E7389 Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes — Completed
• Study of the Combination of Rituximab, Cyclophosphamide, Doxorubicin, VELCADE, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Mantle Cell Lymphoma — Completed
• Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and Asthma — Stopped early
• Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic Cancer — Completed